Research investment strategy
Meningitis Research Foundation has, as its ultimate goal, the elimination of meningitis and septicaemia. The Foundation aims to do this by supporting high quality and innovative research into the prevention, detection and treatment of these diseases.
Research funded must be of the highest scientific merit, in terms of the importance of the investigation, excellence of the study, ability of the research team, and probability of success. Research proposals must demonstrate clear relevance to the disease area and have potential for prevention of these diseases or other clinical or public health benefit.
The trustees place particular emphasis on research into prevention of serogroup B meningococcal infection, due to its prevalence in the UK and Ireland. This especially includes research to enable and monitor vaccine implementation.
Until all forms of meningitis and septicaemia are eradicated, priority will be given to research that produces results in immediate problem areas, including
Prevention of all forms of meningitis and associated infections
- Improving treatment and outlook for patients
- Improving the speed and accuracy of diagnosis
Research may be clinical, laboratory based, or epidemiological. The Foundation will consider funding basic science, but this must increase understanding of the disease area and have a clearly defined potential for early translation into alleviation of the diseases.
Research applications are assessed through a stringent, highly competitive peer review process. The Foundation is an active member of the Association of Medical Research Charities and the Medical Research Charities Group and supports AMRC policies on peer review, good research practice, the use of animals in research and university indirect costs.
Meningitis Research Foundation seeks to fund research that is most likely to defeat meningitis and septicaemia.